These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20443364)

  • 1. [Solid-state NMR spectroscopy and its pharmaceutical use].
    Marosi A; Szalay Z; Demeter A
    Acta Pharm Hung; 2010; 80(1):18-45. PubMed ID: 20443364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of low-level PTFE contamination: An application of solid-state NMR to structure elucidation in the pharmaceutical industry.
    Pham TN; Day CJ; Edwards AJ; Wood HR; Lynch IR; Watson SA; Bretonnet AS; Vogt FG
    J Pharm Biomed Anal; 2011 Jan; 54(2):401-5. PubMed ID: 20880648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of solid-state NMR to pharmaceutical polymorphism and related matters.
    Harris RK
    J Pharm Pharmacol; 2007 Feb; 59(2):225-39. PubMed ID: 17270076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction.
    Liu J; Nagapudi K; Kiang YH; Martinez E; Jona J
    Drug Dev Ind Pharm; 2009 Aug; 35(8):969-75. PubMed ID: 19360510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of ligand-receptor systems by high-resolution solid-state NMR: recent progress and perspectives.
    Luca S; Heise H; Lange A; Baldus M
    Arch Pharm (Weinheim); 2005 Jun; 338(5-6):217-28. PubMed ID: 15938000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of solid-state NMR in pharmaceutical analysis.
    Vogt FG
    Future Med Chem; 2010 Jun; 2(6):915-21. PubMed ID: 21426109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of REDOR NMR in natural product chemistry.
    Matsuoka S; Inoue M
    Chem Commun (Camb); 2009 Oct; (38):5664-75. PubMed ID: 19774235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising reaction performance in the pharmaceutical industry by monitoring with NMR.
    Bernstein MA; Stefinović M; Sleigh CJ
    Magn Reson Chem; 2007 Jul; 45(7):564-71. PubMed ID: 17534884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
    Tishmack PA; Bugay DE; Byrn SR
    J Pharm Sci; 2003 Mar; 92(3):441-74. PubMed ID: 12587108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing anhydrous and hydrous forms of an active pharmaceutical ingredient in a tablet formulation using solid-state NMR spectroscopy.
    Griffin JM; Martin DR; Brown SP
    Angew Chem Int Ed Engl; 2007; 46(42):8036-8. PubMed ID: 17847137
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple-sample probe for solid-state NMR studies of pharmaceuticals.
    Nelson BN; Schieber LJ; Barich DH; Lubach JW; Offerdahl TJ; Lewis DH; Heinrich JP; Munson EJ
    Solid State Nucl Magn Reson; 2006 Feb; 29(1-3):204-13. PubMed ID: 16246531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-state NMR as an analytical tool: quantitative aspects.
    Ziarelli F; Caldarelli S
    Solid State Nucl Magn Reson; 2006 Feb; 29(1-3):214-8. PubMed ID: 16229992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of solid-state 35Cl NMR to the structural characterization of hydrochloride pharmaceuticals and their polymorphs.
    Hamaed H; Pawlowski JM; Cooper BF; Fu R; Eichhorn SH; Schurko RW
    J Am Chem Soc; 2008 Aug; 130(33):11056-65. PubMed ID: 18656917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state NMR spectroscopy of the quadrupolar halogens: chlorine-35/37, bromine-79/81, and iodine-127.
    Bryce DL; Sward GD
    Magn Reson Chem; 2006 Apr; 44(4):409-50. PubMed ID: 16425199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyphenated HPLC-NMR and its applications in drug discovery.
    Peng SX
    Biomed Chromatogr; 2000 Oct; 14(6):430-41. PubMed ID: 11002280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved solid-state NMR quantifications of active principles in pharmaceutical formulations.
    Sanchez S; Ziarelli F; Viel S; Delaurent C; Caldarelli S
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):683-7. PubMed ID: 18479881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of conformational polymorphism in pharmaceutical solids using solid-state NMR and electronic structure calculations.
    Smith JR; Xu W; Raftery D
    J Phys Chem B; 2006 Apr; 110(15):7766-76. PubMed ID: 16610872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing solenoid microcoils for wide-line solid-state NMR.
    Yamauchi K; Janssen JW; Kentgens AP
    J Magn Reson; 2004 Mar; 167(1):87-96. PubMed ID: 14987602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending the scope of NMR spectroscopy with microcoil probes.
    Schroeder FC; Gronquist M
    Angew Chem Int Ed Engl; 2006 Nov; 45(43):7122-31. PubMed ID: 16991159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-state NMR in the analysis of drugs and naturally occurring materials.
    Paradowska K; Wawer I
    J Pharm Biomed Anal; 2014 May; 93():27-42. PubMed ID: 24173236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.